Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 81

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 81
---
 or perceptions about inadequate corporate governance practices or fraudulent accounting, corporate structure or other matters of other Chinese companies may also negatively affect the attitudes of investors towards Chinese companies in general, including us, regardless of whether we have conducted any inappropriate activities. In addition, securities markets may from time to time experience significant price and volume fluctuations that are not related to our operating performance, such as the large decline in share prices in the United States, China and other jurisdictions in late 2008, early 2009 and the second half of 2011, which may have a material adverse effect on the market price of the Class A Ordinary Shares.

In addition to the above factors, the price and trading volume of the Class A Ordinary Shares may be highly volatile due to multiple factors, including the following:

| ● | regulatory                                                
 developments affecting us, our customers or our industry; |

| ● | conditions in the homeopathic                                                                       
 industry in Hong Kong and other regions where we will conduct our business in the future (if any) ; |

| ● | announcements of studies                                                                               
 and reports relating to the quality of our products and service offerings or those of our competitors; |

| ● | changes in the economic                                                          
 performance or market valuations of other companies in the homeopathic industry; |

| ● | actual or anticipated fluctuations                                                       
 in our quarterly results of operations and changes or revisions of our expected results; |

| ● | changes in financial estimates   
 by securities research analysts; |

| ● | announcements by us or                                                                                                              
 our competitors of new product and service offerings, acquisitions, strategic relationships, joint ventures or capital commitments; |

| ● | additions to or departures 
 of our senior management;  |

| ● | detrimental negative publicity            
 about us, our management or our industry; |

| ● | fluctuations of exchange                        
 rates between the Renminbi and the U.S. dollar; |

| ● | release or expiry of lock-up                                                   
 or other transfer restrictions on our outstanding Class A Ordinary Shares; and |

| ● | sales or perceived potential                 
 sales of additional Class A Ordinary Shares. |

<div align='center'>41</div>

We may experience extreme stock price volatility unrelated to our actual or expected operating performance, financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of our Class A Ordinary Shares.

Recently, there have been instances of extreme stock price run-ups followed by rapid price declines and strong stock price volatility with a number of recent initial public offerings, especially among companies with relatively smaller public floats. As